Testing growth hormone to improve embryo chromosome screening results
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This Phase 3 study tests whether growth hormone given during IVF can improve the chance of getting embryos with the “right” number of chromosomes, which is checked by PGT-A. It may help some people who are 38 or older planning chromosome testing of embryos.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 38 or older and planning IVF with PGT-A (embryo chromosome testing)
- Your BMI is in the normal range (18.5 to 24.0)
- Your male partner has a normal semen test result
- You do not have serious endometriosis (grade 3 or higher) or an untreated blocked fallopian tube (hydrosalpinx)
- Your uterus shape and lining have no major issues (like an untreated uterine septum, certain fibroids/polyps, adenomyosis, or major congenital shape problems)
- You are not planning PGT-SR or PGT-M (testing for structural chromosome problems or single-gene conditions), and you do not have certain hormone/immune/thrombosis conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new, more efficient way to perform genetic testing on embryos (PGT-M) for couples who do not have a DNA sample from an affected child. It aims to help families where standard methods are difficult, such as when the carrier has no symptoms, or when the female partner has low egg reserve.
This Phase 3 study compares two hormone/medication schedules to help women with PCOS grow embryos, then checks embryo genetic status using PGT-A. It may help determine which protocol leads to better “euploid” (chromosome-normal) blastocysts for transfer.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
This study tests an upgraded method to screen embryos for genetic abnormalities before implantation during fertility treatment. It may help couples with age-related fertility concerns, repeated implantation failures, recurrent miscarriages, or male factor infertility achieve successful pregnancy.
This trial is for women aged 35–40 doing IVF. It compares genetic testing of embryos before transfer to standard care, to see if it improves pregnancy success.
This study looks at using embryo genetic testing before pregnancy in IVF for women aged 35 to 40. It may help by identifying which embryos are more likely to lead to a healthy pregnancy, though you would still be screened to confirm you fit the criteria.
Hear when a new Preimplantation Genetic Testing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.